{"name":"Vicept Therapeutics, Inc.","slug":"vicept-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxOTzd0VHZtSWZSWldNOTU5eGNfM0JDczRScHVuZElzUFBVakpHcUdKaUV2MkZOQmhFMVgyQjNRd3d4cFdTUDFEQl9ZLXo2ZmpwN1pJSS0wcFJqRHpZVWR5N281QlZFWndraU1uSVVpWjNqUG9RVnBJamVxN1NVREhNM0MzYkdlM0RCeEp3TzdsUE9mdy1XZ1U3RmxIeVNMSExQUjhWOUdTX3lkRm1KN0NqN09PVjhWZ3FuSWFwbTdnWjhGeHlPTXIzczUxTnJ2V2x5RnRjZmZzcFJfa3FGcFRCOHRkQUZiR1V1OHBYSVJ3MzNVb3lYSWhPVUNlUE1yWmpRMmJrZ0NlTF9sazdDSmpOWlhFTzFjMnl6SjdpcjBzbVpDdDZyeE5DZUVXaS1tQnZncmsyWFNMVDRJRjctclBFaU9qa1duNFFDSkxpQTY4Z28?oc=5","date":"2024-01-15","type":"pipeline","source":"PR Newswire","summary":"Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies - Pfizer, ModernaTX, Tarsus Pharmaceuticals, Valneva, Cortene - PR Newswire","headline":"Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNaWdMRXlJTXpkeC00YmdGV0d0dGtfVnpKb1Z6NlpDbVNHemd2OHNlZ3daOE94eVV3aTU4ZUtkTkRDN2o0ZE1EOWpqdGp5NHJqYkpfZ0ZtWXMyWXhya2FvNHFhNXplazh4QnkxWS02TTJ6MVJ1U0JPWFJqa1JXQ0Vfc2lBS29NZkQ2NXNHWjFFRTdIMnhnR0o4TUN6UDhZdw?oc=5","date":"2023-06-30","type":"pipeline","source":"BioPharma Dive","summary":"F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing in a downturn - BioPharma Dive","headline":"F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing in a downturn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPM1ZSVmRuRGt0RjdNZ09jOHZDbHRpQktTbXJrVkIteHlLZUFWMlBNT0IzbEpCaXAwcDA0Y3BSWXU2R042bmlQSjQwemFUN3Z4X1FhWU9qX2tTa2dWRUZYeUJXbmEwd2dpU1Y2VjlQV2dPRlg5WGFnV1VBYmNKZTc4eG1zaTRHbE1kQXFMemFUM0E?oc=5","date":"2015-06-15","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"AltheRx Merging Into New Company to Advance Solabegron - Genetic Engineering and Biotechnology News","headline":"AltheRx Merging Into New Company to Advance Solabegron","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}